A prospective, multicenter case-control study published in PLoS Medicine in 2025 described the frequency and clinical characteristics of patients with a protracted post-Covid course and searched for risk factors for persistence vs. improvement of symptoms. The analyses showed that in two thirds of the patients who had a post-Covid syndrome 6-12 months after acute SARS-CoV-2 infection, symptoms persisted in the following months.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Age-related neurocognitive disorders
Neuroprotective effects of Ginkgo biloba extract
How origin and place of residence promote CF-associated diabetes
- Patients with leg swelling
DVT and other common DDs with peripheral edema
- Pancreatic Cancer
Innovative early detection with a focus on liquid biopsy and AI
- Cervical Cancer
HPV prevention, screening innovation and sentinel lymph node biopsy
- Polypharmacy: use of eHealth tools in Switzerland
Survey study in primary care
- From symptom to diagnosis
Abdominal pain – Prostate abscess
- Asthma during pregnancy